Bioxcell InVivoMAb recombinant Flt-3L-Ig (hum/hum) Clone: Flt-3L Fc-G1 BE0342 5… and 1 more item

Bio X Cell has been awarded contract A207_PO-0440219-V3 by the University of Virginia, a contracting organization located in Virginia. The award was issued on June 13, 2026, with a cumulative contract value of $3,670.80. The contract encompasses the supply of specialized laboratory reagents for research applications, specifically monoclonal antibodies and recombinant proteins used in immunological research.

The contract deliverables include two primary line items: 1,246 units of BioXCell InVivoMAb recombinant Flt-3L-Ig (human/human) Clone Flt-3L Fc-G1 BE0342 5 milligram units, and 2,424 units of BioXCell InVivoMAb anti-mouse Programmed Death-Ligand 1 (B7-H1) BE0101 50 milligram units. Both products are biopharmaceutical research reagents designed for in vivo applications. The supplies are to be delivered to the University of Virginia as the buyer. The line item unit pricing is listed at $1.00 per unit for each product category.